Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1124504.RAW0FSlm8ixMOWsZXaFBB_x3GNUsM8V0YCAu6qGif0fP0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1124504.RAW0FSlm8ixMOWsZXaFBB_x3GNUsM8V0YCAu6qGif0fP0130_assertion type Assertion NP1124504.RAW0FSlm8ixMOWsZXaFBB_x3GNUsM8V0YCAu6qGif0fP0130_head.
- NP1124504.RAW0FSlm8ixMOWsZXaFBB_x3GNUsM8V0YCAu6qGif0fP0130_assertion description "[MSH2 was reduced in 23.4% of NSCLC patients and was significantly associated with adenocarcinoma (P=0.024).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124504.RAW0FSlm8ixMOWsZXaFBB_x3GNUsM8V0YCAu6qGif0fP0130_provenance.
- NP1124504.RAW0FSlm8ixMOWsZXaFBB_x3GNUsM8V0YCAu6qGif0fP0130_assertion evidence source_evidence_literature NP1124504.RAW0FSlm8ixMOWsZXaFBB_x3GNUsM8V0YCAu6qGif0fP0130_provenance.
- NP1124504.RAW0FSlm8ixMOWsZXaFBB_x3GNUsM8V0YCAu6qGif0fP0130_assertion SIO_000772 24185125 NP1124504.RAW0FSlm8ixMOWsZXaFBB_x3GNUsM8V0YCAu6qGif0fP0130_provenance.
- NP1124504.RAW0FSlm8ixMOWsZXaFBB_x3GNUsM8V0YCAu6qGif0fP0130_assertion wasDerivedFrom befree-2016 NP1124504.RAW0FSlm8ixMOWsZXaFBB_x3GNUsM8V0YCAu6qGif0fP0130_provenance.
- NP1124504.RAW0FSlm8ixMOWsZXaFBB_x3GNUsM8V0YCAu6qGif0fP0130_assertion wasGeneratedBy ECO_0000203 NP1124504.RAW0FSlm8ixMOWsZXaFBB_x3GNUsM8V0YCAu6qGif0fP0130_provenance.